Women With Early-Stage SCC Of Vulva, With Negative SLN At Time Of Surgery, May Have Low Risk Of Recurrent Disease In Groin, Study Suggests

Cancer Therapy Advisor (3/30, Moench) reports “results of a large prospective observational study that followed women with early-stage squamous cell carcinoma (SCC) of the vulva characterized by a negative sentinel lymph node biopsy (SLN) at the time of surgery showed these patients to have a low risk of recurrent disease in the groin.” In the study, “following exclusion of the patients with protocol violations, the adjusted rate of isolated groin metastases was 2.7%.” The “findings were submitted to the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer and presented virtually.”